We are live on ! Find out more
MAP

Madison Avenue Partners Portfolio holdings

AUM $2.3B
1-Year Est. Return 115.82%
This Fund
S&P 500
This Quarter Est. Return
+34.48%
1 Year Est. Return
+115.82%
3 Year Est. Return
+241.12%
5 Year Est. Return
+319.41%
10 Year Est. Return
–
AUM
$1.68B
AUM Growth
+$178M
Cap. Flow
-$144M
Cap. Flow %
-8.58%
Top 10 Hldgs %
86.9%
Holding
29
New
3
Increased
5
Reduced
7
Closed
9

Top Buys

Rank Stock Value
1
BTI icon
British American Tobacco
BTI
+$66.4M
2
GMED icon
Globus Medical
GMED
+$48.1M
3
NWSA icon
News Corp Class A
NWSA
+$43.1M
4
AIV
Aimco
AIV
+$17.4M
5
CTRI icon
Centuri Holdings
CTRI
+$14.7M

Top Sells

Rank Stock Value
1
SNDK
Sandisk
SNDK
+$88.1M
2
SAGE
Sage Therapeutics
SAGE
+$55.4M
3
WLY icon
John Wiley & Sons Class A
WLY
+$35.6M
4
INDV icon
Indivior Pharmaceuticals
INDV
+$30.5M
5
INVX
Innovex International
INVX
+$27.6M

Sector Composition

Rank Sector Weight
1 Healthcare 42.15%
2 Industrials 17.27%
3 Technology 13.81%
4 Financials 9.85%
5 Communication Services 8.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLRX icon
26
Pliant Therapeutics
PLRX
$65M
– –
-2,230,012
Closed -$2.59M
SAGE
27
DELISTED
Sage Therapeutics
SAGE
– –
-6,077,065
Closed -$55.4M
INVX
28
Innovex International
INVX
$2.13B
– –
-1,767,997
Closed -$27.6M
MRP
29
Millrose Properties Inc
MRP
$4.87B
– –
-825,804
Closed -$23.5M
1
2

Similar funds

LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return
LFM
LGT Fund Management Vaduz, Liechtenstein $2.3B AUM 22.66% 1-Year Est. Return
GCP
Greenoaks Capital Partners Orinda, California $2.3B AUM 19.87% 1-Year Est. Return
NSAM
North Star Asset Management Neenah, Wisconsin $2.31B AUM 10.09% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $2.32B AUM 30.12% 1-Year Est. Return

Madison Avenue Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Madison Avenue Partners held 29 positions worth $1.68B, up 12% from $1.5B the previous quarter. Its ten largest holdings account for 87% of the portfolio.

Madison Avenue Partners withdrew a net $144M in Q3 2025, closing 9 positions and reducing 7 holdings. Its most notable exit was Sage Therapeutics, an estimated $55.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, down from 44% a quarter earlier, followed by Industrials and Technology.

Against the trend, Madison Avenue Partners opened a new position in British American Tobacco worth $65M.

  • Madison Avenue Partners's largest Q3 2025 buy was British American Tobacco: 1,223,767 shares worth $65M.
  • Madison Avenue Partners added most to Globus Medical in Q3 2025, an estimated $48.1M increase.
  • Madison Avenue Partners's biggest Q3 2025 reduction was Sandisk, cutting an estimated $88.1M.
  • Madison Avenue Partners fully exited Sage Therapeutics in Q3 2025, selling an estimated $55.4M.
  • Madison Avenue Partners's ten largest holdings make up 87% of its $1.68B portfolio in Q3 2025.
  • Madison Avenue Partners opened 3 new positions and closed 9 in Q3 2025.
  • Madison Avenue Partners's portfolio value rose 12% quarter-over-quarter to $1.68B.

Based on Madison Avenue Partners's 13F filing for Q3 2025, filed 14 Nov 2025.